Ovagen

Overview

A short synthetic peptide bioregulator from the Khavinson family, marketed for liver and intestinal/immune support. Evidence is largely Russian-language and preclinical.

Mechanism of Action

Proposed tissue-specific peptide-bioregulator activity in hepatic/GI tissue; not established by independent research.

Research Summary

Primarily Russian institutional studies; no large independent controlled human trials.

Vendors selling Ovagen

Scored vendors carrying Ovagen, ranked by trust grade. Grades are computed from indexed Certificates of Analysis. Full $/mg pricing is on the comparison page.

Reported Side Effects

• Not well characterized

Frequently asked questions

Has Ovagen been independently lab-tested?

Disclosed Labs has collected 6 Certificates of Analysis (COA) for Ovagen from 4 independent testing labs. 4 vendors have submitted material for testing. Products average 99.0% tested purity across the corpus. Full testing data is available at https://www.disclosedlabs.com/peptides/ovagen/testing.

What is the average purity of Ovagen on the market?

Based on 6 COAs analyzed by Disclosed Labs, Ovagen products average 99.0% (±0.6%) tested purity. Individual vendor results vary; see per-vendor COA data at https://www.disclosedlabs.com/peptides/ovagen/coas.

Where can researchers source Ovagen?

2 vendors with Disclosed Labs trust grades currently list Ovagen, including Verified Peptides, BioLongevity Labs. Compare live prices and lab-verified COAs at https://www.disclosedlabs.com/prices/ovagen.

How does Ovagen work?

Proposed tissue-specific peptide-bioregulator activity in hepatic/GI tissue; not established by independent research.

What does the research say about Ovagen?

Primarily Russian institutional studies; no large independent controlled human trials.